China Universal Asset Management Co. Ltd. boosted its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.

A new study using Mendelian randomization suggests that higher copper levels may increase fibromyalgia risk, while iron may ...

Dr. Sterling Elliott, Clinical Pharmacist at Northwestern Medicine and Assistant Professor of Orthopedics at Feinberg School ...

Yoga can help relieve sciatica pain and even prevent it from returning, as it helps improve spinal alignment and release tension. Here are the poses that help the most.

The new FDA-approved pain drug is suzetrigine, with the brand name Journavx. Suzetrigine is designed to alleviate moderate to ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved in pain signaling.

Experts with the Cleveland Clinic say the drug has a lot of potential, especially since it is considered nonaddictive.

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...